Literature DB >> 3312036

[Ceftazidime in the treatment of pediatric infections--a review].

D Adam1, R Tolxdorff-Neutzling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3312036     DOI： 10.1007/BF01645872

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  15 in total

1.  Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration.

Authors:  A Boccazzi; M Rizzo; M L Caccamo; B M Assael
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

2.  Clinical pharmacology of ceftazidime in paediatrics.

Authors:  B M Assael; A Boccazzi; M L Caccamo; A Giunta; A Marini; R Padoan; F Rusconi; F Sereni
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

3.  Pharmacokinetics of ceftazidime in newborn infants.

Authors:  G H McCracken; N Threlkeld; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

4.  Ceftazidime in the treatment of neonatal infection.

Authors:  I Pollock; A Mulhall; J de Louvois
Journal:  J Hosp Infect       Date:  1985-06       Impact factor: 3.926

5.  Ceftazidime as a single agent in the management of children with fever and neutropenia.

Authors:  G Morgan; B I Duerden; J S Lilleyman
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

6.  Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old.

Authors:  S Snelling; C A Hart; R W Cooke
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

7.  Ceftazidime in the treatment of chronic suppurative otitis media in children.

Authors:  P Lautala; M Vare; O Vuorinen; M L Kaar
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

8.  Ceftazidime in the treatment of febrile immunosuppressed children.

Authors:  P J Darbyshire; P J Williamson; S J Pedler; D C Speller; M G Mott; A Oakhill
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

9.  A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants.

Authors:  J G Prinsloo; S D Delport; J Moncrieff; A M Paton
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

10.  Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.